LISA DABBS: Open Payments
NPI 1689950040 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,110 in 157 payments from 18 companies in 2025. Trend: 2023 $2,784 · 2024 $2,891 · 2025 $3,110
Food & beverage: $3,000Education: $110
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $537 |
| Axsome Therapeutics, Inc. | 25 | $428 |
| ABBVIE INC. | 21 | $425 |
| Teva Pharmaceuticals USA, Inc. | 10 | $338 |
| Vanda Pharmaceuticals Inc. | 14 | $221 |
| Collegium Pharmaceutical, Inc. | 12 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $164 |
| Otsuka America Pharmaceutical, Inc. | 5 | $147 |
| Supernus Pharmaceuticals, Inc. | 6 | $130 |
| E.R. Squibb & Sons, L.L.C. | 5 | $106 |
Products named: CAPLYTA, Auvelity, VRAYLAR, AUSTEDO XR, FANAPT, REXULTI, Jornay PM, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
